Fosun International Limited (0656.HK)
| Previous close | 4.460 |
| Open | 4.460 |
| Bid | 4.500 x 0 |
| Ask | 4.510 x 0 |
| Day's range | 4.460 - 4.530 |
| 52-week range | 3.930 - 5.780 |
| Volume | |
| Avg. volume | 2,500,252 |
| Market cap | 36.775B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 25.00 |
| EPS (TTM) | 0.180 |
| Earnings date | 28 Mar 2024 |
| Forward dividend & yield | 0.04 (0.84%) |
| Ex-dividend date | 12 Jun 2024 |
| 1y target est | 6.18 |
PR NewswireFOSUN FOR GOOD, CREATING IMPACT: Fosun International Issued its 2023 ESG Report and the Second Climate Information Disclosures Report
Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today issued the Environmental, Social and Governance (ESG) Report 2023 (the "ESG Report"). Facing the increasingly severe challenges of global climate change, Fosun released its second Climate Information Disclosures Report with reference to the disclosure requirements of the Hong Kong Stock Exchange, the Task Force on Climate-Related Financial Disclosures ("TCFD
BloombergBNP Paribas to Buy Fosun’s Stake in Belgian Insurer Ageas
(Bloomberg) -- BNP Paribas SA agreed to buy Fosun International Ltd.’s 9% stake in insurer Ageas for about €730 million ($777 million), tightening the French lender’s relationship with its partner in a Belgian business. Most Read from BloombergIsrael Versus Iran — What All-Out War Could Look LikeApple Faces Worst iPhone Slump Since Covid as China Rivals RiseTexas Warns of Possible Power Emergency Next WeekSingapore PM Lee to Hand Reins to Wong After Two DecadesIran’s Missile Barrage Was an Error
PR NewswireFosun's Subsidiary Fidelidade Announces Listing Plan of Private Health Service Company Luz Saúde
Fidelidade, a subsidiary of Fosun International and Portugal's leading insurer, announced on Wednesday (10 April) that its subsidiary, Luz Saúde, a private healthcare service provider had communicated to the market its plan to seek admission for the trading of its shares on the Euronext Lisbon stock exchange, as part of a planned public sale offer. If realized, this operation will create better conditions for the continued expansion and growth of Luz Saúde in the health sector.
